Deluxe STD Panel Testing

Deluxe STD Panel

Includes:
Chlamydia trachomatis and Neisseria gonorrhoeae by nucleic acid amplification technology;
Herpes Simplex Virus (HSV) Type II Antibodies, IgG;
Human Immunodeficiency Virus 1/O/2 (HIV-1/O/2) Antigen/Antibody (Fourth Generation) Preliminary Test With Cascade Reflex to Supplementary Testing when Antibody test is reactive.
Syphilis (RPR), qualitative; RPR titer and Treponema pallidum-specific test (TP-PA) on reactives;
Complete Blood Count (CBC): Hematocrit; hemoglobin; mean corpuscular volume (MCV); mean corpuscular hemoglobin (MCH); mean corpuscular hemoglobin concentration (MCHC); red cell distribution width (RDW); percentage and absolute differential counts; platelet count; red cell count; white blood cell count; immature granulocytes;
Urinalysis Complete Profile: Color; appearance; specific gravity; pH; protein; glucose; occult blood; ketones; leukocyte esterase; nitrite; bilirubin; urobilinogen; microscopic examination of urine sediment.

Patient Instructions: First-Void Urine needed - Patient should take first urine of the day to the lab or should not urinate for at least 1 hour prior to specimen collection. Fasting is not required. This test may exhibit interference when sample is collected from a person who is consuming a supplement with a high dose of biotin (also termed as vitamin B7 or B8, vitamin H or coenzyme R). It is recommended to stop biotin consumption at least 72 hours prior to the collection of specimen.

Estimated turnaround for results is 3 business days.

Chlamydia (Chlamydia trachomatis) and Gonorrhea (Neisseria gonorrhoeae): The Chlamydia and Gonorrhea test examines patients for the presence of both sexually-transmitted diseases, detected by their bacteriums, which are frequently the most reported in the country.

Herpes Simples Virus (HSV) Type II Antibodies, IgG : The Herpes Simplex Virus (HSV) Type II, IgG test is used to determine the presence of Type 2 (HSV-2) Herpes Simplex in a patient. Most Genital Herpes are caused by HSV-2. Positive results may require further evaluation by your physician.

HIV-1/O/2 (Human Immunodeficiency Virus 1/O/2 Antibodies, Preliminary Test With Confirmation) : The HIV-1 Antibodies test screens patients for the presence of HIV-1 antibodies. It is appropriate for exposure at least 6 months prior to testing.

Syphilis (RPR), qualitative and Syphilis (RPR) titer and Treponema pallidum-specific test (TP-PA) on reactives: These Syphilis tests discover the presence of the Treponema pallidum bacterium, which is an indication of a Syphilis infection in a patient.